These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 11972436)

  • 21. Clinical aspects of antenatal enhancement of pulmonary maturation.
    Coustan DR
    Clin Perinatol; 1987 Sep; 14(3):697-711. PubMed ID: 3311545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Choice and dose of corticosteroid for antenatal treatments.
    Jobe AH; Soll RF
    Am J Obstet Gynecol; 2004 Apr; 190(4):878-81. PubMed ID: 15118606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple courses of antenatal glucocorticoid treatment and fetal outcome.
    Lacaze-Masmonteil T; Audibert F
    J Perinat Med; 2000; 28(3):185-93. PubMed ID: 10923302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucocorticoid programming of pituitary-adrenal function: mechanisms and physiological consequences.
    O'Regan D; Welberg LL; Holmes MC; Seckl JR
    Semin Neonatol; 2001 Aug; 6(4):319-29. PubMed ID: 11972433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antenatal steroid treatment and adverse fetal effects: what is the evidence?
    Kay HH; Bird IM; Coe CL; Dudley DJ
    J Soc Gynecol Investig; 2000; 7(5):269-78. PubMed ID: 11035278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Undesired effects of steroids during pregnancy.
    Mariotti V; Marconi AM; Pardi G
    J Matern Fetal Neonatal Med; 2004 Nov; 16 Suppl 2():5-7. PubMed ID: 15590425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Factors affecting fetal lung maturation. Prevention of respiratory distress syndrome in premature infants].
    Zajac T
    Wiad Lek; 1986 Jul; 39(13):926-32. PubMed ID: 3788156
    [No Abstract]   [Full Text] [Related]  

  • 28. Antenatal glucocorticoid treatment is not associated with long-term metabolic risks in individuals born before 32 weeks of gestation.
    Finken MJ; Keijzer-Veen MG; Dekker FW; Frölich M; Walther FJ; Romijn JA; van der Heijden BJ; Wit JM;
    Arch Dis Child Fetal Neonatal Ed; 2008 Nov; 93(6):F442-7. PubMed ID: 18450806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maternal glucocorticoid treatment and reduction of risk from respiratory distress syndrome.
    Taeusch HW; Wong YL; Torday JS; Epstein MF
    J Reprod Med; 1979 Nov; 23(5):252-6. PubMed ID: 513050
    [No Abstract]   [Full Text] [Related]  

  • 30. Respiratory morbidity in late-preterm infants: prevention is better than cure!
    Jain L
    Am J Perinatol; 2008 Feb; 25(2):75-8. PubMed ID: 18214813
    [No Abstract]   [Full Text] [Related]  

  • 31. [Influence of antenatal steroids on perinatal mortality and morbidity in extremely low birth weight newborns].
    Stranák Z; Velebil P; Mechurová A
    Sb Lek; 2003; 104(4):345-52. PubMed ID: 15320525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined ACTH and glucocorticoid treatment improves survival and organ maturation in premature newborn calves.
    Schmidt M; Sangild PT; Blum JW; Andersen JB; Greve T
    Theriogenology; 2004 Jun; 61(9):1729-44. PubMed ID: 15019468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New frontiers in prenatal prevention of respiratory distress syndrome.
    Cosmi EV
    J Perinat Med; 1991; 19 Suppl 1():170-5. PubMed ID: 1779354
    [No Abstract]   [Full Text] [Related]  

  • 34. Placental P-glycoprotein is unaffected by timing of antenatal glucocorticoid therapy but reduced in SGA preterm infants.
    Hodyl NA; Stark MJ; Butler M; Clifton VL
    Placenta; 2013 Apr; 34(4):325-30. PubMed ID: 23425635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single versus repeat courses of antenatal steroids to improve neonatal outcomes: risks and benefits.
    Bonanno C; Fuchs K; Wapner RJ
    Obstet Gynecol Surv; 2007 Apr; 62(4):261-71. PubMed ID: 17371606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Tocolysis: which are the benefits?].
    Di Renzo GC; Donati Sarti R; Gori F; Gerli S
    Minerva Ginecol; 2006 Dec; 58(6):479-87. PubMed ID: 17108878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Glucocorticoid treatment in preterm birth].
    Salim R; Nachum Z; Shalev E
    Harefuah; 1999 Nov; 137(10):481-6. PubMed ID: 10959351
    [No Abstract]   [Full Text] [Related]  

  • 38. [The effect of glucocorticoids and other prenatal factors on fetal lung maturity].
    Melková J; Pokorný A; Broscheová M; Srp B; Hájek Z
    Cesk Pediatr; 1986 Nov; 41(11):658-63. PubMed ID: 3791473
    [No Abstract]   [Full Text] [Related]  

  • 39. [Corticosteroid for fetal lung maturation: indication and treatment protocols].
    Senat MV
    J Gynecol Obstet Biol Reprod (Paris); 2002 Nov; 31(7 Suppl):5S105-13. PubMed ID: 12454632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of a prolonged time interval between antenatal corticosteroid administration and delivery on outcomes in preterm neonates: a cohort study.
    Ring AM; Garland JS; Stafeil BR; Carr MH; Peckman GS; Pircon RA
    Am J Obstet Gynecol; 2007 May; 196(5):457.e1-6. PubMed ID: 17466700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.